CancerCareE
Cedars-Sinai Medical Center Los Angeles
#2 Hospital in the USA • #7 Cancer Center Nationally • Global Leader in Cellular Therapy
US News 2025: #2 Overall
Beds: 886
JCI Accredited
TIL Therapy Available
Hospital Overview
Cedars-Sinai Medical Center is consistently ranked the #2 hospital in the United States and #7 for cancer (U.S. News & World Report 2025). The Samuel Oschin Comprehensive Cancer Institute is a world leader in precision oncology, cellular immunotherapy (CAR-T & TIL), robotic surgery, and early-phase clinical trials.
#2
Hospital USA
#7
Cancer USA
886
Licensed Beds
190+
Countries Served
Cost Comparison – USA vs Leading Asian Centers (2025)
| Treatment | Cedars-Sinai USA | Bumrungrad Thailand | Asan Korea | CAMS China |
|---|---|---|---|---|
| CAR-T Therapy | $450K–$550K | Not available | $300K–$400K | $45K–$70K |
| TIL Therapy (Amtagvi) | $515,000 (FDA approved) | Not available | Not available | Clinical trial only |
| Robotic Prostatectomy | $65K–$95K | $18K–$30K | $40K–$65K | $10K–$18K |
| Phase I Trial Access | Extensive (Top 5 West Coast) | Limited | Moderate | Growing |
| Overall Survival (Advanced Cases) | Highest globally | Very Good | Excellent | Good & improving |
Cutting-Edge Treatments Available
Cellular Immunotherapy
- All 6 FDA-approved CAR-T products
- FDA-approved TIL therapy (Amtagvi/Lifileucel) – one of first centers worldwide
- Bispecific antibodies, next-gen CAR-NK/TCR-T trials
Surgical Excellence
- Highest-volume robotic surgery program in California
- Intraoperative MRI, fluorescence-guided surgery
- Organ-preserving and reconstructive techniques
Precision & Research
- Liquid biopsy, AI-driven treatment selection
- Top 5 phase I trial enrollment on West Coast
- MR-Linac, ViewRay adaptive radiotherapy
Available Advanced Treatments
| Treatment | Availability |
|---|---|
| All FDA CAR-T Products | Available |
| FDA-Approved TIL Therapy (Amtagvi) | Routine |
| Phase I/II Clinical Trials | Top 5 West Coast |
| Robotic Surgery (da Vinci Xi) | Highest volume in CA |
| MR-Linac & Adaptive RT | Available |
| Proton Therapy | Nearby partnership |
Frequently Asked Questions (FAQ)
Can international patients receive CAR-T or TIL therapy at Cedars-Sinai?
Yes. The International Health Program accepts patients from all countries for all FDA-approved cellular therapies with proper medical documentation and visa.
What is the typical waiting time?
Consultation: 1–3 weeks. CAR-T/TIL infusion: 4–8 weeks after insurance/pre-approval. Urgent cases can be fast-tracked.
Do you accept international insurance?
Yes – direct billing with Allianz, Cigna Global, Bupa Global, AXA, Etiqa, Gulf insurers and many others.
Is a US visa required?
Yes (B-2 medical visa). Cedars-Sinai provides official invitation letters and full visa support.
Contact & Location
Main Campus
8700 Beverly Boulevard
Los Angeles, CA 90048
United States
International Patients
Phone: +1-310-423-3277
International Office: +1-323-442-0182
Email: international@cshs.org
WhatsApp: Available
Ready for Treatment at America’s #2 Hospital?
Get access to FDA-approved TIL therapy, all CAR-T products, and the most advanced cancer trials in the world.
Request Free Consultation